As synthesized in Table 2, clustering of the study population according to the development of HCC during follow-up highlighted a difference in the distribution of baseline values of log10(SCCA-IgM), higher in those that finally experienced HCC. The gene discussed is CD40LG; the disease is hepatocellular carcinoma.